UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Pathogenic mutations in Parkinson disease

Human Mutation, 2007-07, Vol.28 (7), p.641-653

2007

Link zum Volltext

Verfügbarkeit prüfen

DbVar and DGVa: public archives for genomic structural variation

Nucleic acids research, 2013-01, Vol.41 (Database issue), p.D936

2013

Link zum Volltext

Verfügbarkeit prüfen

Genomic investigation of α-synuclein multiplication and parkinsonism

Annals of neurology, 2008-06, Vol.63 (6), p.743-750

2008

Link zum Volltext

Verfügbarkeit prüfen

Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice

Neuron (Cambridge, Mass.), 2005-07, Vol.47 (2), p.191-199

2005

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

Science (American Association for the Advancement of Science), 2001-08, Vol.293 (5534), p.1487-1491

2001

Link zum Volltext

Verfügbarkeit prüfen

Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease

Movement disorders, 2006-07, Vol.21 (7), p.997-1001

2006

Link zum Volltext

Verfügbarkeit prüfen

Fine-mapping and candidate gene investigation within the PARK10 locus

European journal of human genetics : EJHG, 2009-03, Vol.17 (3), p.336-343

2009

Link zum Volltext

Verfügbarkeit prüfen

α-Synuclein promoter confers susceptibility to Parkinson's disease

Annals of neurology, 2004-10, Vol.56 (4), p.591-595

2004

Link zum Volltext

Verfügbarkeit prüfen

Linkage Disequilibrium and Association of MAPT H1 in Parkinson Disease

American journal of human genetics, 2004-10, Vol.75 (4), p.669-677

2004

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease

Human molecular genetics, 2005-12, Vol.14 (23), p.3549-3556

2005

Link zum Volltext

Verfügbarkeit prüfen

The Tau H1 Haplotype is associated with Parkinson's disease in the Norwegian population

Neuroscience letters, 2002-04, Vol.322 (2), p.83-86

2002

Link zum Volltext

Verfügbarkeit prüfen

Parkinson’s Genetics: Molecular Insights for the New Millennium

Neurotoxicology (Park Forest South), 2002-10, Vol.23 (4), p.503-514

2002

Link zum Volltext

Verfügbarkeit prüfen

LRRK2 G2019S founder haplotype in the Chinese population

Movement disorders, 2007-01, Vol.22 (1), p.105-107

2007

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease

Expert opinion on pharmacotherapy, 2006-05, Vol.7 (7), p.849-855

2006

Link zum Volltext

Verfügbarkeit prüfen

Parkinson's disease in Ireland: Clinical presentation and genetic heterogeneity in patients with parkin mutations

Movement disorders, 2004-06, Vol.19 (6), p.677-681

2004

Link zum Volltext

Verfügbarkeit prüfen

P4-158 Tau H1 haplotype disease association and splice mutations: investigations into mutational mechanisms

Neurobiology of aging, 2004-07, Vol.25, p.S520-S520

2004

Link zum Volltext

Verfügbarkeit prüfen

Polymorphisms in candidate genes: implications for the current treatment of Parkinson s disease

Expert opinion on pharmacotherapy, Vol.7 (7), p.849-855

Link zum Volltext

Verfügbarkeit prüfen

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

Neuron (Cambridge, Mass.), 2005-07, Vol.47 (2), p.191-199

2005

Link zum Volltext

Verfügbarkeit prüfen

A[beta]42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice

Neuron (Cambridge, Mass.), 2005-07, Vol.47 (2), p.191

2005

Link zum Volltext

Verfügbarkeit prüfen

Parkinson's disease susceptibility: Genetic mapping in an isolated population

Skipper, Lisa Marie

2005

Link zum Volltext
ProQuest

Identification of the Human Ubiquitin Specific Protease 31 (USP31) Gene: Structure, Sequence and Expression Analysis

DNA sequence, 2004-02, Vol.15 (1), p.9-14

2004

Link zum Volltext

Verfügbarkeit prüfen

Outcomes for physicians with opioid dependence treated without agonist pharmacotherapy in physician health programs

Journal of substance abuse treatment, 2016-05, Vol.64, p.47-54

2016

Link zum Volltext

Verfügbarkeit prüfen

Essential components of physician health program monitoring for substance use disorder: A survey of participants 5 years post successful program completion

The American journal on addictions, 2022-03, Vol.31 (2), p.115-122

2022

Link zum Volltext

Verfügbarkeit prüfen

Family Risk for Depression and Prioritization of Religion or Spirituality: Early Neurophysiological Modulations of Motivated Attention

Frontiers in human neuroscience, 2019-12, Vol.13, p.436-436

2019

Link zum Volltext

Verfügbarkeit prüfen

Family Risk for Depression and Prioritization of Religion or Spirituality: Early Modulations of Event-Related Potentials to Unpleasant Pictures

Biological psychiatry (1969), 2020-05, Vol.87 (9), p.S173

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(30)
Dissertationen
(1)

Sprache

Englisch
(31)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathogenic mutations in Parkinson disease

DbVar and DGVa: public archives for genomic structural variation

Genomic investigation of α-synuclein multiplication and parkinsonism

Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice

Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease

Fine-mapping and candidate gene investigation within the PARK10 locus

α-Synuclein promoter confers susceptibility to Parkinson's disease

Linkage Disequilibrium and Association of MAPT H1 in Parkinson Disease

Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease

The Tau H1 Haplotype is associated with Parkinson's disease in the Norwegian population

Parkinson’s Genetics: Molecular Insights for the New Millennium

LRRK2 G2019S founder haplotype in the Chinese population

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease

Parkinson's disease in Ireland: Clinical presentation and genetic heterogeneity in patients with parkin mutations

P4-158 Tau H1 haplotype disease association and splice mutations: investigations into mutational mechanisms

Polymorphisms in candidate genes: implications for the current treatment of Parkinson s disease

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

A[beta]42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice

Parkinson's disease susceptibility: Genetic mapping in an isolated population

Identification of the Human Ubiquitin Specific Protease 31 (USP31) Gene: Structure, Sequence and Expression Analysis

Outcomes for physicians with opioid dependence treated without agonist pharmacotherapy in physician health programs

Essential components of physician health program monitoring for substance use disorder: A survey of participants 5 years post successful program completion

Family Risk for Depression and Prioritization of Religion or Spirituality: Early Neurophysiological Modulations of Motivated Attention

Family Risk for Depression and Prioritization of Religion or Spirituality: Early Modulations of Event-Related Potentials to Unpleasant Pictures

Suchergebnisse filtern